MedTrace Logo

Effectiveness Evaluation of a Self-management Program for Prostate Cancer Survivors

NCT05335967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2025-01-03

No results posted yet for this study

Summary

Objectives: This project aims to develop a self-management program for survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy and determine its effectiveness.

Methods: The investigators will develop a self-management program and conduct a study on survivors with prostate cancer experiencing urinary incontinence following radical prostatectomy. And the investigators will test the effectiveness of the self-management program. After completing a pretest, participants will be randomly assigned to the experimental or control group. The self-management group will receive the self-management program for 12 weeks, whereas the information group will receive an information package on a healthy diet. Posttests will be administered 12 and 16 weeks after the pretest. The study variables will include physical symptoms and bothers, cancer-related self-efficacy, social participation, demoralization, and resilience.

Conditions

  • Prostatic Neoplasms
  • Self-Management

Interventions

BEHAVIORAL

Self-management program

The self-management group will receive the self-management program for 12 weeks, including a self-management application, a self-management manual, and Professional support.

OTHER

Information package

The patients in this group will receive an information package on a healthy diet.

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • National Science and Technology Council

    collaborator FED

  • National Taipei University of Nursing and Health Sciences

    lead OTHER

Principal Investigators

  • Ching-Hui Chien, PhD · National Taipei University of Nursing and Health Sciences, Taipei, Taiwan.

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-20
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05335967 on ClinicalTrials.gov